US Stock MarketDetailed Quotes

IBO Impact BioMedical

Watchlist
  • 388.500
  • 0.0000.00%
Close Jul 5 09:30 ET
4.47BMarket Cap-961633P/E (TTM)

Impact BioMedical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0.00%50K
0
0
50K
Operating revenue
--0
--0
--0
--0
--0
--0
0.00%50K
--0
--0
--50K
Cost of revenue
Gross profit
Operating expense
-3.99%771K
16.62%4.03M
10.37%1.14M
21.26%1.08M
26.00%1.01M
13.26%803K
0.00%3.45M
-23.16%1.03M
14.23%889K
26.16%800K
Selling and administrative expenses
28.78%434K
57.94%1.76M
70.69%396K
99.64%559K
46.20%462K
28.14%337K
0.00%1.12M
-52.07%232K
-9.68%280K
118.69%316K
-Selling and marketing expense
-52.94%8K
----
----
----
----
--17K
----
----
----
----
-General and administrative expense
33.13%426K
57.94%1.76M
70.69%396K
99.64%559K
46.20%462K
21.67%320K
0.00%1.12M
-52.07%232K
-9.68%280K
118.69%316K
Research and development costs
-72.07%50K
-6.44%1.15M
-11.30%463K
-27.58%239K
29.13%266K
6.55%179K
0.00%1.23M
-10.15%522K
73.96%330K
-2.55%206K
Depreciation amortization depletion
0.00%280K
0.63%1.12M
0.72%280K
0.36%280K
0.72%280K
0.72%280K
0.00%1.11M
0.00%278K
0.17%279K
-0.08%278K
-Depreciation and amortization
0.00%280K
0.63%1.12M
0.72%280K
0.36%280K
0.72%280K
0.72%280K
0.00%1.11M
0.00%278K
0.17%279K
-0.08%278K
Other operating expenses
0.00%7K
----
----
----
----
--7K
----
----
----
----
Operating profit
3.99%-771K
-18.33%-4.03M
-10.37%-1.14M
-21.26%-1.08M
-34.40%-1.01M
-13.26%-803K
0.00%-3.4M
20.19%-1.03M
-14.23%-889K
-18.27%-750K
Net non-operating interest income expense
-131.63%-227K
1.60%-431K
31.84%-122K
-11.24%-99K
-130.61%-113K
-164.86%-98K
0.00%-438K
47.81%-179K
25.79%-89K
-299.14%-49K
Non-operating interest income
0.00%3K
-45.83%13K
103.75%3K
0.00%3K
-96.67%3K
-96.88%3K
0.00%24K
-35.59%-80K
-94.66%3K
249.20%90K
Non-operating interest expense
127.72%230K
-3.90%444K
26.26%125K
10.87%102K
-16.55%116K
-24.06%101K
0.00%462K
-65.14%99K
-47.75%92K
11,810.88%139K
Other net income (expense)
101.29%52K
0
52K
0.00%-4.03M
Special income (charges)
----
--0
----
----
----
----
0.00%-4.1M
----
----
----
-Write off
----
--0
----
----
----
----
0.00%4.1M
----
----
----
Other non- operating income (expenses)
----
-21.21%52K
--0
----
----
--52K
0.00%66K
----
----
----
Income before tax
-17.55%-998K
44.05%-4.41M
75.96%-1.26M
-20.35%-1.18M
-40.30%-1.12M
-13.81%-849K
0.00%-7.88M
8.70%-5.25M
-6.25%-978K
-55.99%-799K
Income tax
0
0
0
0
0
0
0.00%-621K
-378.12%-1.88M
1,258,100.00%1.26M
0
Net income
-17.55%-998K
39.26%-4.41M
62.54%-1.26M
47.36%-1.18M
-40.30%-1.12M
-13.81%-849K
0.00%-7.26M
37.11%-3.37M
-142.95%-2.24M
-87.99%-799K
Net income continuous Operations
-17.55%-998K
39.26%-4.41M
62.54%-1.26M
47.36%-1.18M
-40.30%-1.12M
-13.81%-849K
0.00%-7.26M
37.11%-3.37M
-142.95%-2.24M
-87.99%-799K
Minority interest income
81.25%-36K
65.20%-71K
-550.00%-26K
77.61%-15K
71.64%-19K
-149.35%-192K
0.00%-204K
-105.13%-4K
41.72%-67K
25.30%-67K
Net income attributable to the parent company
-46.42%-962K
38.51%-4.34M
63.27%-1.24M
46.43%-1.16M
-50.55%-1.1M
1.79%-657K
0.00%-7.05M
38.08%-3.36M
-169.30%-2.17M
-118.29%-732K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-46.42%-962K
38.51%-4.34M
63.27%-1.24M
46.43%-1.16M
-50.55%-1.1M
1.79%-657K
0.00%-7.05M
38.08%-3.36M
-169.30%-2.17M
-118.29%-732K
Basic earnings per share
-46.42%-0.0837
38.51%-0.377
63.27%-0.1074
46.43%-0.101
-50.55%-0.0958
1.79%-0.0571
0.00%-0.6131
38.08%-0.2923
-169.30%-0.1886
-118.29%-0.0637
Diluted earnings per share
-46.42%-0.0837
38.51%-0.377
63.27%-0.1074
46.43%-0.101
-50.55%-0.0958
1.79%-0.0571
0.00%-0.6131
38.08%-0.2923
-169.30%-0.1886
-118.29%-0.0637
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000.00%50K0050K
Operating revenue --0--0--0--0--0--00.00%50K--0--0--50K
Cost of revenue
Gross profit
Operating expense -3.99%771K16.62%4.03M10.37%1.14M21.26%1.08M26.00%1.01M13.26%803K0.00%3.45M-23.16%1.03M14.23%889K26.16%800K
Selling and administrative expenses 28.78%434K57.94%1.76M70.69%396K99.64%559K46.20%462K28.14%337K0.00%1.12M-52.07%232K-9.68%280K118.69%316K
-Selling and marketing expense -52.94%8K------------------17K----------------
-General and administrative expense 33.13%426K57.94%1.76M70.69%396K99.64%559K46.20%462K21.67%320K0.00%1.12M-52.07%232K-9.68%280K118.69%316K
Research and development costs -72.07%50K-6.44%1.15M-11.30%463K-27.58%239K29.13%266K6.55%179K0.00%1.23M-10.15%522K73.96%330K-2.55%206K
Depreciation amortization depletion 0.00%280K0.63%1.12M0.72%280K0.36%280K0.72%280K0.72%280K0.00%1.11M0.00%278K0.17%279K-0.08%278K
-Depreciation and amortization 0.00%280K0.63%1.12M0.72%280K0.36%280K0.72%280K0.72%280K0.00%1.11M0.00%278K0.17%279K-0.08%278K
Other operating expenses 0.00%7K------------------7K----------------
Operating profit 3.99%-771K-18.33%-4.03M-10.37%-1.14M-21.26%-1.08M-34.40%-1.01M-13.26%-803K0.00%-3.4M20.19%-1.03M-14.23%-889K-18.27%-750K
Net non-operating interest income expense -131.63%-227K1.60%-431K31.84%-122K-11.24%-99K-130.61%-113K-164.86%-98K0.00%-438K47.81%-179K25.79%-89K-299.14%-49K
Non-operating interest income 0.00%3K-45.83%13K103.75%3K0.00%3K-96.67%3K-96.88%3K0.00%24K-35.59%-80K-94.66%3K249.20%90K
Non-operating interest expense 127.72%230K-3.90%444K26.26%125K10.87%102K-16.55%116K-24.06%101K0.00%462K-65.14%99K-47.75%92K11,810.88%139K
Other net income (expense) 101.29%52K052K0.00%-4.03M
Special income (charges) ------0----------------0.00%-4.1M------------
-Write off ------0----------------0.00%4.1M------------
Other non- operating income (expenses) -----21.21%52K--0----------52K0.00%66K------------
Income before tax -17.55%-998K44.05%-4.41M75.96%-1.26M-20.35%-1.18M-40.30%-1.12M-13.81%-849K0.00%-7.88M8.70%-5.25M-6.25%-978K-55.99%-799K
Income tax 0000000.00%-621K-378.12%-1.88M1,258,100.00%1.26M0
Net income -17.55%-998K39.26%-4.41M62.54%-1.26M47.36%-1.18M-40.30%-1.12M-13.81%-849K0.00%-7.26M37.11%-3.37M-142.95%-2.24M-87.99%-799K
Net income continuous Operations -17.55%-998K39.26%-4.41M62.54%-1.26M47.36%-1.18M-40.30%-1.12M-13.81%-849K0.00%-7.26M37.11%-3.37M-142.95%-2.24M-87.99%-799K
Minority interest income 81.25%-36K65.20%-71K-550.00%-26K77.61%-15K71.64%-19K-149.35%-192K0.00%-204K-105.13%-4K41.72%-67K25.30%-67K
Net income attributable to the parent company -46.42%-962K38.51%-4.34M63.27%-1.24M46.43%-1.16M-50.55%-1.1M1.79%-657K0.00%-7.05M38.08%-3.36M-169.30%-2.17M-118.29%-732K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -46.42%-962K38.51%-4.34M63.27%-1.24M46.43%-1.16M-50.55%-1.1M1.79%-657K0.00%-7.05M38.08%-3.36M-169.30%-2.17M-118.29%-732K
Basic earnings per share -46.42%-0.083738.51%-0.37763.27%-0.107446.43%-0.101-50.55%-0.09581.79%-0.05710.00%-0.613138.08%-0.2923-169.30%-0.1886-118.29%-0.0637
Diluted earnings per share -46.42%-0.083738.51%-0.37763.27%-0.107446.43%-0.101-50.55%-0.09581.79%-0.05710.00%-0.613138.08%-0.2923-169.30%-0.1886-118.29%-0.0637
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg